Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Speculation on the supplemental amendment to 148/Opty/Eggbert...S...

Thank you for your input.

In that interview summary it states that it was agreed that the instruction processing aspect of the term "processing unit" could be clafified on the record without amending the claims and the examiner would need time to fully consider the arguments presented by Hennman re:control signals of Kagigaya. Also the examiner stated he needed time to reconsider the rejection of Bagula in view of Tanimura.

That was the last we heard from the examiner. Then the re-ex was merged. We don't, in the latest documents, have his answer, just "housekeeping" amendments to bring both re-ex's to the same condition so that the proceedings may continue(similar to the merged '749). See Decision Merging Proceedings 10-02-2009.

This is how I understand it.... BWDIK? Corrections/enlightenment welcomed.

The next examiners' response should be very significant.

GLTAL

Share
New Message
Please login to post a reply